Agenus (Formerly known as Antigenics Inc. - Lexington, MA) to Present at NewsMakers in the Biotech Industry Conference

LEXINGTON, Mass., Oct. 18, 2011 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a developer of therapeutic vaccines for cancer and infectious diseases, today announced that the company will be presenting at the NewsMakers in the Biotech Industry Conference on Friday, October 21st at the Millennium Broadway Hotel & Conference Center in New York City.
MORE ON THIS TOPIC